Neonatal 17‐hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening

201651 citationsJournal Articlebronze Open Access

Authors

Giselle Yuri Hayashi · Associação de Pais e Amigos dos Excepcionais de São Paulo

Daniel Fonseca de Carvalho · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Mirela Costa de Miranda · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Cláudia Faure · Associação de Pais e Amigos dos Excepcionais de São Paulo

Carla Vallejos · Associação de Pais e Amigos dos Excepcionais de São Paulo

Vinícius Nahime Brito · Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Abstract

Neonatal 17-hydroxyprogesterone levels adjusted to sample collection age and birthweight reduced the FPR, and the use of N17OHP values based upon the 99·8th percentile improved the NBS efficacy.

Topics & Keywords

Sexual Differentiation and Disorders Blood groups and transfusion Hormonal and reproductive studies

Publication Details

Published in: Clinical Endocrinology

Volume 86, Issue 4, pp. 480-487

DOI: 10.1111/cen.13292

Field-Weighted Citation Impact: 2.26

Command Palette

Neonatal 17‐hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening

Authors

Abstract

Topics & Keywords

Publication Details